Latest News about Fda
Recent news which mentions Fda
Psychedelics Reform Update: Congress, California, Kentucky Opioids, Oregon, Nevada And More
July 10, 2023
From Benzinga
Iovance's Update Provides Reassurance With Upcoming Lifileucel's FDA Action Date, Analyst Says
July 10, 2023
Tickers
IOVA
From Benzinga
Infinity Pharmaceuticals Says Second Proxy Advisory Firm Recommends Shareholders To Approve Proposed Merger
July 10, 2023
From Benzinga
Chuck Schumer Calls For FDA Probe Into YouTube Star Logan Paul's Energy Drink: 'Beware...An Eye Popping Level Of Caffeine'
July 10, 2023
From Benzinga
From Benzinga
BrainStorm Cell Therapeutics Shares Fall After Updated Biomarker Data From Lead Cell Therapy Candidate
July 07, 2023
Tickers
BCLI
From Benzinga
Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures
July 06, 2023
Tickers
CMPS
From Benzinga
80% Of US Voters Support Easing Research Restrictions, Plus Other Insights From UC-Berkeley Poll
July 05, 2023
From Benzinga
Inside UC Berkeley's Nation-Representative Psychedelics Survey: Unveiling Unexpected Data
July 05, 2023
From Benzinga
Abbott Scores FDA Nod For First Dual-Chamber Leadless Pacemaker To Treat Abnormal, Slow Heart Rhythms
July 05, 2023
Tickers
ABT
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.